Edward Liebow

Edward Liebow

Auto-generated profile, based on publicly available information

Edward Liebow

Battelle Centers for Public Health Research and Evaluation, USA

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Clinical Microbiology Reviews
Verified
Journal Article
Open access
PDF file
SBStephanie S. Buehler
Stephanie S. Buehler
BMBereneice Madison
Bereneice Madison
SSSusan R. Snyder
Susan R. Snyder
JDJames H. Derzon
James H. Derzon
NCNancy E. Cornish
Nancy E. Cornish
DWDonna M. Wolk
Donna M. Wolk
SUMMARY: Background.: Bloodstream infection (BSI) is a major cause of morbidity and mortality throughout the world. Rapid identification of bloodstream pathogens is a laboratory practice that supports strategies for rapid transition to direct targeted therapy by providing for timely and effective patient care. In fact, the more rapidly that appropriate antimicrobials are prescribed, the lower the mortality for patients with sepsis. Rapid identification methods may have multiple positive impacts on patient outcomes, including reductions in mortality, morbidity, hospital lengths of stay, and antibiotic use. In addition, the strategy can reduce the cost of care for patients with BSIs. Objectives.: The purpose of this review is to evaluate the evidence for the effectiveness of three rapid diagnostic practices in decreasing the time to targeted therapy for hospitalized patients with BSIs. The review was performed by applying the Centers for Disease Control and Prevention's (CDC's) Laboratory Medicine Best Practices Initiative (LMBP) systematic review methods for quality improvement (QI) practices and translating the results into evidence-based guidance (R. H. Christenson et al., Clin Chem 57 :816–825, 2011, http://dx.doi.org/10.1373/clinchem.2010.157131 ). Search strategy.: A comprehensive literature search was conducted to identify studies with measurable outcomes. A search of three electronic bibliographic databases (PubMed, Embase, and CINAHL), databases containing “gray” literature (unpublished academic, government, or industry evidence not governed by commercial publishing) (CIHI, NIHR, SIGN, and other databases), and the Cochrane database for English-language articles published between 1990 and 2011 was conducted in July 2011. Dates of search.: The dates of our search were from 1990 to July 2011. Selection criteria.: Animal studies and non-English publications were excluded. The search contained the following medical subject headings: bacteremia; bloodstream infection; time factors; health care costs; length of stay; morbidity; mortality; antimicrobial therapy; rapid molecular techniques, polymerase chain reaction (PCR); in situ hybridization, fluorescence; treatment outcome; drug therapy; patient care team; pharmacy service, hospital; hospital information systems; Gram stain; pharmacy service; and spectrometry, mass, matrix-assisted laser desorption-ionization. Phenotypic as well as the following key words were searched: targeted therapy; rapid identification; rapid; Gram positive; Gram negative; reduce(ed); cost(s); pneumoslide; PBP2; tube coagulase; matrix-assisted laser desorption/ionization time of flight; MALDI TOF; blood culture; EMR; electronic reporting; call to provider; collaboration; pharmacy; laboratory; bacteria; yeast; ICU; and others. In addition to the electronic search being performed, a request for unpublished quality improvement data was made to the clinical laboratory community. Main results.: Rapid molecular testing with direct communication significantly improves timeliness compared to standard testing. Rapid phenotypic techniques with direct communication likely improve the timeliness of targeted therapy. Studies show a significant and homogeneous reduction in mortality associated with rapid molecular testing combined with direct communication. Author's conclusions.: No recommendation is made for or against the use of the three assessed practices of this review due to insufficient evidence. The overall strength of evidence is suggestive; the data suggest that each of these three practices has the potential to improve the time required to initiate targeted therapy and possibly improve other patient outcomes, such as mortality. The meta-analysis results suggest that the implementation of any of the three practices may be more effective at increasing timeliness to targeted therapy than routine microbiology techniques for identification of the microorganisms causing BSIs. Based on the included studies, results for all three practices appear applicable across multiple microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive S. aureus (MSSA), Candida species, and Enterococcus species.

1 September 2012 in Clinical Biochemistry
Verified
Journal Article
Closed access
SSSusan R. Snyder
Susan R. Snyder
AFAlessandra M. Favoretto
Alessandra M. Favoretto
RBRich Ann Baetz
Rich Ann Baetz
JDJames H. Derzon
James H. Derzon
BMBereneice M. Madison
Bereneice M. Madison
ELEdward B. Liebow
Edward B. Liebow

1 September 2012 in Clinical Biochemistry
Verified
Journal Article
Closed access
NHNicholas J. Heyer
Nicholas J. Heyer
JDJames H. Derzon
James H. Derzon
LWLinda Winges
Linda Winges
CSColleen Shaw
Colleen Shaw
DMDiana Mass
Diana Mass
ELEdward B. Liebow
Edward B. Liebow

1 September 2012 in Clinical Biochemistry
Verified
Journal Article
Closed access
SSSusan R. Snyder
Susan R. Snyder
AFAlessandra M. Favoretto
Alessandra M. Favoretto
JDJames H. Derzon
James H. Derzon
RCRobert H. Christenson
Robert H. Christenson
SKStephen E. Kahn
Stephen E. Kahn
ELEdward B. Liebow
Edward B. Liebow

1 June 2011 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
RCRobert H. Christenson
Robert H. Christenson
SSSusan R Snyder
Susan R Snyder
CSColleen S Shaw
Colleen S Shaw
JDJames H Derzon
James H Derzon
RBRobert S Black
Robert S Black
ELEdward B Liebow
Edward B Liebow
OBJECTIVE: To develop methods for systematically reviewing evidence for identifying effective laboratory medicine (LM) practices associated with improved healthcare quality outcomes. RELEVANCE: Although many evidence-evaluation systems have been developed, none are designed to include and rate healthcare quality improvement studies to identify evidence-based practices that improve patient safety and LM quality. METHODS: Validated evidence-based medicine methods established by governmental agencies, the Guide to Community Preventive Services, and others were adapted for the LM field. Key methods modifications included (a) inclusion of quality improvement study designs; (b) mechanisms for inclusion of unpublished evidence, (c) combining of individual ratings of study quality, effect size, and relevance of outcome measures to evaluate consistency of practice evidence; and (d) deriving an overall strength rating to support evidence-based best practice recommendations. The methods follow the process steps of: ask; acquire; appraise; analyze; apply; and assess. Expert panels used the systematic evidence review results on practice effectiveness for improving healthcare quality outcomes consistent with the Institute of Medicine's healthcare quality aims (safe, timely, effective, equitable, efficient, and patient-centered). CONCLUSIONS: Adapting and developing methods from validated systems and applying them to systematically review and evaluate practices in LM by using published and unpublished studies is feasible. With these methods, evidence from quality improvement studies can be systematically synthesized and summarized to identify effective LM practices. Practical and scientifically validated demonstration of a positive impact on outcomes ensures that practitioners, policy makers, and decision makers at all levels have the evidence needed for improving healthcare quality and public health.

1 September 2012 in Clinical Biochemistry
Verified
Journal Article
Closed access
ELEdward B. Liebow
Edward B. Liebow
JDJames H. Derzon
James H. Derzon
JFJohn Fontanesi
John Fontanesi
AFAlessandra M. Favoretto
Alessandra M. Favoretto
RBRich Ann Baetz
Rich Ann Baetz
SSSusan R. Snyder
Susan R. Snyder